Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
22,713 | Dovepress* | 18,235+ | 3,420 | 21,655 | |
PubMed Central* | 4,478 | 2,051 | 6,529 | ||
Totals | 22,713 | 5,471 | 28,184 | ||
*Since 5 July 2014 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar